3rd ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology
30 ESCO credits
20.05.2016 - 25.05.2016
Bratislava, Slovak Republic
MASTERCLASS
Description
Chairs: T. Cufer, SI - R. Herrmann, CH
ESO Masterclass Coordinator: N. Pavlidis, GR
This residential programme has been designed for young medical and clinical oncologists, who wish to improve their skills or those who are preparing for the national board or ESMO exam. The programme will expose participants to a full spectrum of issues in clinical and medical oncology from basic science to advanced knowledge of systemic therapy as well as in the multidisciplinary treatment approach. It is intended to cover all major topics of ESMO-ASCO curriculum on medical oncology.
The programme focuses on cancer pathology and molecular biology, cancer genetics, pharmacology of anti-cancer drugs and on frequent cancers such as breast, lung, gastro-intestinal, gynaecological and head and neck cancer. Spotlight sessions will provide inside on state of the art approaches in melanoma, sarcoma, thyroid cancer and on palliative care. Furthermore, practical training will be offered in the frame of clinical case presentations, prepared and presented by the participants and faculty for an interactive discussion.
All participants will reside at the Masterclass venue and participation is mandatory throughout the course. At the end of each of the five days a learning self-assessment discussion with the chairs of the course will be provided.
LEARNING OBJECTIVES
• Update the knowledge on basic science of clinical and medical oncology
• Enhance the competence and practical performance in systemic therapy of malignancies
• Enhance the competence and practical performance in multidisciplinary cancer care
• Update knowledge and get additional skills in supportive as well as palliative care
• Prepare for the board exam in clinical/medical oncology
MAIN TOPICS
• Cancer biology/pathology
• Cancer genetics
• Pharmacology of anti-cancer drugs
• Breast cancer
• Gastro-intestinal tumours
• Lung cancer and mesothelioma
• Genito-urinary cancers
• Palliative and supportive care
• Haematological malignancies
THE MASTERCLASS IS:
• A five day residential, educational event
• Full immersion
• Clinically oriented
• Multidisciplinary
The Eastern Europe |
![]() |
||
General information
ORGANISING SECRETARIAT
Alexandra Zampetti and Dolores Knupfer
European School of Oncology (ESO)
Piazza Indipendenza, 2
6500 Bellinzona, Switzerland
Email: azampetti@eso.net or dknupfer@eso.net
Tel: +41 91 820 09 52/54
CME ACCREDITATION AND CERTIFICATE
The 3rd ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net
The programme has been granted up to 28 European CME credits (ECMEC). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.
The programme is furthermore accredited with 25 ESMO-MORA category 1 points.
Participants will receive their certificate of attendance via e-mail after the event on completion of the evaluation form.
Faculty list
FACULTY (as of March 2016)
P. Berzinec, Institute of Tuberculosis and Respiratory Diseases, Nitra-Zobor, SK
J. Beyer, University Hospital Zürich, CH
M.J. Cardoso, Champalimaud Cancer Center, Lisbon, PT
A. Cervantes, University of Valencia, Valencia, ES
A. Costa, CEO, European School of Oncology, Milan, IT and Bellinzona, CH
T. Cufer, University Clinic Golnik, SI
M. Ebert Moltara, Oncology Institute, Ljubljana, SI
A. Eniu, Cancer Institute « I. Chiricuta”, Cluj-Napoca, RO
M.F. Fey, Inselspital, Berne, CH
A. Fusi, Charité Comprehensive Cancer Center, Berlin, DE
K. Heinimann, University Hospital, Basel, CH
R. Herrmann, University Hospital, Basel, CH
M.A. Hoda, Medical University Vienna, AT
M. Joerger, Cantonal Hospital St. Gallen, CH
D. Jovanovic, Clinical Center of Serbia, Belgrade, RS
I. Kern, University Clinic Golnik, SI
F. Krasniqi, University Hospital Basel, CH
T. Marinko, Institute of Oncology Ljubljana, SI
N. Pavlidis, University Hospital of Ioannina, GR
R. Popescu, Hirslanden Klinik Aarau, CH
A. Reiner, Donau Hospital SMZO, Vienna, AT
P. Roth, University Hospital Zürich, CH
S. Rothschild, University Hospital Basel, CH
B. Šeruga, Institute of Oncology, Ljubljana, SI
C. Sessa, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
S. Spanik, St. Elizabeth Cancer Institute, Bratislava, SK
P. Strojan, Institute of Oncology, Ljubljana, SI
Programme
20 May
Participants arrivals |
||
20:00 | Dinner |
|
21 May
8:15 | Registration |
|
9:00 | Welcome address and general introduction T. Cufer, SI - R. Herrmann, CH |
|
CANCER BIOLOGY Chair: A. Reiner, AT |
||
9:30 | Biology of cancer S. Rothschild, CH |
|
10:00 | Discussion |
|
10:10 |
Cancer genetics for the practising oncologist K. Heinimann, CH |
|
10:40 | Discussion |
|
10:50 | Coffee break |
|
SPOTLIGHT SESSION 1 Chair: S. Rothschild, CH |
||
11:10 |
Pharmacology of anticancer drugs and drug interactions M. Joerger, CH |
|
11:55 |
Discussion |
|
12:05 | Basic principles of immunotherapy and melanoma A. Fusi, DE |
|
12:50 | Discussion |
|
13:00 | Lunch |
|
SPOTLIGHT SESSION 2 Chair: R. Herrmann, CH |
||
14:30 | |
Palliative care M. Ebert Moltara, SI |
14:50 |
Discussion |
|
15:00 | Supportive care M. Ebert Moltara, SI |
|
15:20 |
Discussion |
|
15:30 |
Coffee break | |
16:00 | Head and neck cancers P. Strojan, SI |
|
16:20 | Discussion |
|
16:30 |
Sarcomas including GIST F. Krasniqi, CH |
|
16:50 |
Discussion |
|
17:00 | CNS malignancies P. Roth, CH |
|
17:20 | Discussion |
|
17:30 -18:30 |
Participants' case presentations - Group 1 (4 cases) - T. Cufer, SI - A. Eniu, RO - Group 2 (4 cases) - R. Herrmann, CH - Group 3 (4 cases) - N. Pavlidis, GR |
|
20:00 |
Dinner |
|
22 May
GASTRO-INTESTINAL TUMOURS |
||
9:00 |
Management of esophageal cancer and gastric cancer A. Cervantes, ES |
|
9:45 |
Discussion |
|
10:00 |
Management of early and locally advanced colorectal cancer S. Spanik, SK |
|
10:45 | Discussion |
|
10:55 |
Coffee break |
|
11:05 | Tumor board: Gastro-intestinal tumors: PART 1 Panellists: A. Cervantes, ES - R. Popescu, CH - S. Spanik, SK (4 cases) |
|
11:55 | Systemic treatment of advanced colorectal cancer R. Popescu, CH |
|
12:40 | Discussion |
|
12:50 | Lunch |
|
14:15 | New developments in systemic treatment of hepatobiliary and pancreatic cancer R. Popescu, CH |
|
14:35 | Discussion |
|
14:45 | Tumor board: Gastro-intestinal tumors: PART 2 Panellists: A. Cervantes, ES - R. Popescu, CH - S. Spanik, SK (4 cases) |
|
15:45 | Coffee break |
|
16:00 |
Spotlight session 3 Chair: T. Cufer, SI |
|
16:15 |
Cancer of unknown primary N. Pavlidis, GR |
|
16:35 | Discussion |
|
16:45 |
Neuroendocrine tumors N. Pavlidis, GR |
|
17:05 | Discussion |
|
17:15 -18:15 |
Participants' case presentations |
|
20:00 |
Dinner | |
23 May
BREAST CANCER |
||
9:00 | Breast cancer pathology and molecular biology A. Reiner, AT |
|
9:30 | Discussion |
|
9:40 |
Optimal surgical management of breast cancer M.J. Cardoso, PT |
|
10:00 | Discussion | |
10:10 | The role of radiotherapy in early and advanced BC T. Marinko, SI |
|
10:30 | Discussion | |
10:40 | Coffee break |
|
11:00 |
Optimal approach in locally advanced disease: ESO-ESMO ABC Guidelines A. Eniu, RO |
|
11:30 | Discussion | |
11:40 |
Tumor board: Breast cancer: PART 1 Panellists: M.J. Cardoso, PT - T. Cufer, SI - A. Eniu, RO - T. Marinko, SI - A. Reiner, AT - B. Šeruga, SI (4 cases) |
|
12:40 | Lunch |
|
14:00 | Systemic treatment of Luminal early and advanced BC B. Šeruga, SI |
|
14:30 | Discussion |
|
14:40 |
Systemic treatment of HER2-positive early and advanced BC T. Cufer, SI |
|
15:10 |
Discussion |
|
15:20 | Systemic treatment of TN early and advanced BC A. Eniu, RO |
|
15:50 | Discussion |
|
16:00 | Coffee break |
|
16:15 | Tumor board: Breast cancer: PART 2 Panellists: M.J. Cardoso, PT - T. Cufer, SI - A. Eniu, RO - T. Marinko, SI - A. Reiner, AT - B. Šeruga, SI (4 cases) |
|
SPOTLIGHT SESSION 4 Chair: R. Popescu, CH |
||
17:15 |
Targeted therapies of renal cell carcinoma S. Rothschild, CH |
|
17:35 | Discussion |
|
17:35 -18:45 |
Learning self-assessment discussion R. Herrmann, CH |
|
20:00 |
Off-site dinner: Bratislava Castle | |
24 May
LUNG CANCER AND MESOTHELIOMA Chairs: T. Cufer, SI - D. Jovanovic, RS |
||
9:00 |
Lung cancer pathology and molecular biology I. Kern, SI |
|
9:30 |
Discussion |
|
9:40 | Surgery of lung cancer and mesothelioma M.A. Hoda, AT |
|
10:10 | Discussion |
|
10:20 | Optimal management of N2 disease D. Jovanovic, RS |
|
10:50 | Discussion | |
11:00 | Coffee break |
|
11:15 |
Tumor board: Lung cancer - PART 1 Panellists: T. Cufer, SI – I. Kern, SI - D. Jovanovic, RS - P. Berzinec, SK - M.A. Hoda, AT (4 cases) |
|
12:15 |
Systemic therapy of NSCLC T. Cufer, SI |
|
12:45 | Discussion |
|
12:55 |
Lunch |
|
14:15 | Treatment of SCLC P. Berzinec, SK |
|
14:35 |
Discussion | |
14:45 | Mesothelioma D. Jovanovic, RS |
|
15:05 |
Discussion |
|
15:15 |
Tumor board: Lung cancer PART 2 Panellists: T. Cufer, SI – I. Kern, SI - D. Jovanovic, RS - P. Berzinec, SK - M.A. Hoda, AT (4 cases) |
|
16:15 |
Coffee break |
|
SPOTLIGHT SESSION 5 Chair: D. Jovanovic, RS |
||
16:30 |
New developments in systemic treatment of gynecological cancers C. Sessa, CH |
|
17:05 |
Discussion |
|
17:15 |
Assessment of patients’ comorbidity and comprehensive geriatric assessment B. Šeruga, SI |
|
17:50 | Discussion |
|
20:00 | Dinner |
|
25 May
GENITO-URINARY CANCERS Chair: R. Herrmann, CH |
||
8:30 |
New developments in systemic therapy of germ cell tumors J. Beyer, CH |
|
9:00 | Discussion |
|
9:10 | Systemic therapy of bladder cancer B. Šeruga, SI |
|
9:40 | Discussion |
|
9:50 |
Systemic therapy of prostate cancer J. Beyer, CH |
|
10:35 |
Discussion | |
11:25 | Tumor board: Genito-urinary Panellists: J. Beyer, CH - B. Šeruga, SI (4 cases) |
|
12:25 | Brunch |
|
SPOTLIGHT SESSION 6 Chair: T. Cufer, SI |
||
13:00 |
Introduction A. Costa, CH/IT |
|
13:05 | Hiba Basic Memorial Lecture: Personalised Medicine in 2016: realities and future hopes M.F. Fey, CH |
|
13:50 | Discussion |
|
14:00 | Close T. Cufer, SI |
|
Departures | ||